Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fletcher

Showing results (1391-1400 of 1,501) with videos related to

Pageof 151
Sort By:
Cell Reports|August 24, 2022
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's diseaseDavid T Asuzu, Reinier Alvarez, Patrick A Fletcher, et al.
IJID Regions|July 7, 2023
Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational studyWanatpreeya Phongsamart, Kristen E Allen, Warunee Punpanich Vandepitte, et al.
Oncogene|October 8, 2021
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumorAlfonso García-Valverde, Jordi Rosell, Sergi Sayols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patientsAndrew P Garner, Joseph M Gozgit, Rana Anjum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinasesMichael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Plos One|August 20, 2011
A molecular assay for sensitive detection of pathogen-specific T-cellsVictoria O Kasprowicz, Jessica E Mitchell, Shivan Chetty, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2019
Quantification of the Capacity for Cold-Induced Thermogenesis in Young Men With and Without ObesityRobert J Brychta, Shan Huang, Juan Wang, et al.
Pageof 151

Showing results (1391-1400 of 1,501) with videos related to

Sort By:
Pageof 151
Cell Reports|August 24, 2022
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's diseaseDavid T Asuzu, Reinier Alvarez, Patrick A Fletcher, et al.
IJID Regions|July 7, 2023
Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational studyWanatpreeya Phongsamart, Kristen E Allen, Warunee Punpanich Vandepitte, et al.
Oncogene|October 8, 2021
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumorAlfonso García-Valverde, Jordi Rosell, Sergi Sayols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2014
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patientsAndrew P Garner, Joseph M Gozgit, Rana Anjum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinasesMichael C Heinrich, Heikki Joensuu, George D Demetri, et al.
Plos One|August 20, 2011
A molecular assay for sensitive detection of pathogen-specific T-cellsVictoria O Kasprowicz, Jessica E Mitchell, Shivan Chetty, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2019
Quantification of the Capacity for Cold-Induced Thermogenesis in Young Men With and Without ObesityRobert J Brychta, Shan Huang, Juan Wang, et al.
Pageof 151